Companies & Industry »Company News»Company News Details
Company News Details

BSE   29 Jul 16 | 12:00 AM

366.05 4.75 (1.31%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   29 Jul 16 | 12:00 AM

366.90 5.1 (1.41%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 371.80 (-1.55%)
1 Month : Rs 312.25 (17.23%)
1 Year : Rs 375.75 (-2.58%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Adani Ports231.952.95
Lupin1,740.752.15
Bajaj Auto2,702.001.56
Hind. Unilever921.501.47
Cipla528.151.47

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine